Geneieve Tai

Compound heterozygous <i>FXN</i> mutations and clinical outcome in friedreich ataxia

Charles A. Galea, Aamira Huq, Paul J. Lockhart et al. · Annals of Neurology · 2015 · 149 citations

Deferiprone in <scp>F</scp>riedreich ataxia: A 6‐Month randomized controlled trial

Massimo Pandolfo, Javier Arpa, Martin B. Delatycki et al. · Annals of Neurology · 2014 · 128 citations

<i>FXN</i> methylation predicts expression and clinical outcome in Friedreich ataxia

Marguerite V. Evans‐Galea, Nissa Carrodus, Simone M. Rowley et al. · Annals of Neurology · 2011 · 115 citations · Full text

An open-label trial in Friedreich ataxia suggests clinical benefit with high-dose resveratrol, without effect on frataxin levels

Eppie M. Yiu, Geneieve Tai, Roger E. Peverill et al. · Journal of Neurology · 2015 · 110 citations

Open-label Trial, Pharmacology, Clinical Trials +5

Efficacy of a tailored rehabilitation program for systemic sclerosis.

Susanna Maddali Bongi, Angela Del Rosso, Felice Galluccio et al. · PubMed · 2010 · 76 citations